Search results

Page results

• Oxbryta (Voxelotor) withdrawal from the UK market in the treatment of Sickle Cell Disorder in people aged 12 years and older

  Pfizer Limited, in agreement with the Medicines Healthcare products Regulatory Agency (MHRA), has withdrawn the product, while a review of the benefits and risks is carried out.

• Obesity/High body Mass Index– what are the risks?

  This page is for patients with obesity who are waiting for scheduled surgery.

• RESPOND information for service users

  Information for service users about the RESPOND service for refugees and asylum seekers.

• Managing pain after your operation (Easy Read)

  This easy read page offers advice for patients on managing pain after an operation.

• Interventions for prostate cancer patients on active surveillance: what our patients should know

  A major new review published in BJU International explores additional treatments and lifestyle measures for men with early prostate cancer who are managed with active surveillance, as well as monitoring tools that may help guide care.

• Managing cancer treatment side effects videos

  This series of wellbeing videos have been designed to help people manage the side effects of cancer treatment.

• Sperm banking - Information for teenagers and young adults with a cancer diagnosis

  This page explains what sperm banking is, how it works and how it can benefit you.

• Improving clinic attendance and reducing health inequalities in children and young people

  A UCLH rheumatology team is leading an exciting project to help understand the reasons for young people missing their hospital appointments and find ways to improve this.

• New surgical technique preserves continence in men after prostate removal

  A new surgical technique could remove the risk of urinary incontinence after surgery to remove the prostate for men with prostate cancer.

• Study reveals limitations of drug proposed for lung cancer treatment

  Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.